Healthcare -
Biotechnology - NASDAQ - US
$ 15.5
-6.4 %
$ 2.25 B
Market Cap
-6.03
P/E
DNLI - CAPITAL EXPENDITURES
Capital Expenditures DNLI - Denali Therapeutics Inc.
-12.9 M
LAST VALUE
-23.38%
2 YEAR CAGR
-30.70%
5 YEAR CAGR
0.00%
10 YEAR CAGR